HomeStocksTATVA

T

Tatva Chintan Pharma

TATVA Share Price

Chemicals
mtf MTF 1.56x

903.10

-16.25 (-1.77%)loss

as on 30 May 2025 at 15:48

1D
img
154
img
60% Buy
Bulb

Today Tatva Chintan Pharma opened at 918.40 while its previous close was at 919.35. In todays trading session TATVA reached a high of 923.30 and low of 891.05. The average traded price for today is 905.03. The 50 DMA stands at and 200 DMA is at . Looking at intraday trend, the stock is in Downtrend.

chartsarrowTradingViewarrow
TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

TATVA Stock Performance

Markets Today

High

923.30

Low

891.05

Open at

918.40

Prev Close

919.35

Volumes

36,053

Avg Price

905.03

Lower Circuit

722.50

Upper Circuit

1,083.70

Last Traded Details

Quantity

1

Time

15:48:34

Price Movement

891.05
903.10
923.30
Loss 1.35%down side
up side2.19% profit

Historical Performance

3 M High

978.00

3 M Low

621.00

1 Yr High

1,222.00

1 Yr Low

621.00

3 Yr High

2,650.00

3 Yr Low

621.00

5 Yr High

2,977.80

5 Yr Low

621.00

1-Year Performance

621.00
903.10
1,222.00
loss1.35%down side
up side2.19% profit

TATVA Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By Refinitiv from 5 analysts

Buy

60%

Hold

20%

Sell

20%


TATVA Latest News

news

No news for this stock at the moment.


TATVA Share Price History

Close Price

Volume

TATVA share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
30 May 2025918.40903.10
-1.67% Loss
923.30891.0536,053
29 May 2025899.00919.35
2.26% profit
941.85889.951,23,497
28 May 2025906.80883.75
-2.54% Loss
909.00881.0022,609
27 May 2025895.10902.30
0.80% profit
907.90895.0023,290
26 May 2025930.75901.80
-3.11% Loss
937.00894.0551,969
23 May 2025920.90926.15
0.57% profit
940.90906.0558,474
22 May 2025944.60920.55
-2.55% Loss
954.90916.001,38,818
21 May 2025926.00965.85
4.30% profit
978.00886.009,57,289
20 May 2025760.95906.30
19.10% profit
906.30760.9510,33,884
19 May 2025770.00755.25
-1.92% Loss
779.00749.6594,288

TATVA Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

2,113

PE Ratio

376.60

PB Ratio

2.91

Dividend Yield

0.11%

ROE

4.12%

ROCE

6.78%

Book Value (₹)

315.84

Face Value (₹)

10.00


Share Holding Pattern

Held ByMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Promoters
72.02%72.02%72.02%72.02%72.02%
Domestic Institutional Investors (DII)
12.84%10.63%6.82%6.34%5.46%
Foreign Institutional Investors (FII)
3.65%3.37%3.33%3.36%3.30%
Public Investors
10.49%12.44%15.95%16.33%16.92%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


TATVA Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


TATVA Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA00Bullish
10-SMA00Bullish
20-SMA00Bullish
50-SMA00Bullish
100-SMA00Bullish
200-SMA00Bullish

Technical Indicators

IndicatorValueAction
RSI(14)00Bullish
ATR(14)00Bullish
STOCH(14)00Bullish
STOCH RSI(14)00Bullish
MACD(12,26)00Bullish
ADX(14)00Bullish

Summary of Technical Indicators for TATVA


TATVA Financials Summary
View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
1031078486109

TATVA Financials

View By:

Income Statement

In Crores

Quarterly StatementMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Revenue1031078486109
Expenses8393787999
Operating Profit1613679
Operating Profit Margin %16%12%7%8%8%
Other Income51001
EBITDA20146710
Interest00000
Depreciation67777
Profit Before Tax147-1-02
Tax %30%23%35%158%49%
Net Profit105-101
EPS42-000

Balance Sheet

In Crores

Yearly Balance SheetMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Share Capital820222223
Reserve & Surplus110146451493714
Minority Interest00000
Non Current Liabilities44311452
Current Liabilities8811817123980
Total Liabilities249315658759819
Fixed Assets111120160196427
Capital Work in Progress5105223177
Investments000010
Other Assets133185447332305
Total Assets249315658759819

Cash Flow

In Crores

Yearly Cash FlowMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Operating Activities2520202898
Investing Activities-40-21-197-101-121
Financing Activities10-52353831
Net Cash Flow-5-659-368

Past Corporate Actions

DateCorporate ActionInformation
25 Apr 2025
Quarterly Result Announcement
NA
17 Jan 2025
Quarterly Result Announcement
NA
16 Oct 2024
Quarterly Result Announcement
NA
27 Aug 2024
Annual General Meeting
NA
03 May 2024
Dividend
₹ 2.00 /share

ScanX Logo

Get In-depth View of TATVA Quaterly Results, Balance Sheet, Cashflows & Corporate Action.

Use Screener

TATVA Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2023-24386
-6.05% Loss
29
-27.47% Loss
FY 2022-23409
-5.79% Loss
41
-57.84% Loss
FY 2021-22438
46.92% profit
96
86.89% profit

Top Mutual Funds Invested in TATVA

logo

Nippon India Small Cap Fund Direct - Growth

AUM

₹ 58,029 Cr.

1Y Returns

6.13 %

3Y Returns

29.59 %

5Y Returns

41.35 %

logo

ICICI Prudential Commodities Fund Direct - Growth

AUM

₹ 2,620 Cr.

1Y Returns

2.05 %

3Y Returns

21.89 %

5Y Returns

39.07 %

logo

ICICI Prudential Smallcap Fund Direct - Growth

AUM

₹ 7,605 Cr.

1Y Returns

5.30 %

3Y Returns

22.53 %

5Y Returns

37.49 %

logo

SBI Magnum Mid Cap Fund Direct - Growth

AUM

₹ 21,512 Cr.

1Y Returns

9.25 %

3Y Returns

22.33 %

5Y Returns

33.05 %

logo

Nippon India ELSS Tax Saver Fund Direct - Growth

AUM

₹ 14,782 Cr.

1Y Returns

9.12 %

3Y Returns

21.61 %

5Y Returns

27.94 %

logo

ICICI Prudential MNC Fund Direct - Growth

AUM

₹ 1,608 Cr.

1Y Returns

3.00 %

3Y Returns

16.92 %

5Y Returns

25.72 %







What’s New In The Market
I

IndiGo: New Delhi-Jorhat Direct Flight to Launch in September 2025

sentiment_img

IndiGo will start a non-stop flight between Delhi and Jorhat in mid-September 2025. The airline is also enhancing connectivity to other Assam destinations, including Silchar, Dibrugarh, and North Lakhimpur. A new Guwahati-Navi Mumbai route is planned for the 2025-26 winter schedule.

INDIGO

5,330.00

8.00
(0.15%) profit
15 hours ago

N

Taylor Swift: Pop Star Acquires Rights to Her First Six Albums

sentiment_img

Taylor Swift has purchased the master recordings of her first six albums from Shamrock Capital, regaining control over her early music catalog. This acquisition ends a long-standing dispute over ownership of her original recordings, which were previously sold without her consent.

NORTHARC

214.63

-4.12
(-1.88%) profit
17 hours ago

D

DCB Bank: Soccer Shapes CEO Praveen Kutty's Leadership Style

sentiment_img

DCB Bank's CEO Praveen Kutty draws leadership lessons from soccer, emphasizing teamwork, strategic thinking, and adaptability in banking. He applies sports principles to foster ownership, celebrate team success, and manage pressure in the corporate environment.

DCBBANK

147.00

1.44
(0.99%) profit
17 hours ago

FAQs

Tatva Chintan Pharma share price as of today is ₹ 903.10 as on 30 May 2025 at 15:48.
The 52W high of Tatva Chintan Pharma is ₹ 1,222.00 and 52W low is ₹ 621.00 as of 30 May 2025 at 15:48.
The past returns of Tatva Chintan Pharma share are -
  • Past 1 year: -16.59%
  • Past 3 years: -60.70%
  • Past 5 years: -60.94%
The PE and PB ratio of Tatva Chintan Pharma stands at 376.60 and 2.91 respectively as on 30 May 2025 at 15:48.
The EPS of Tatva Chintan Pharma is 0.44 for the quarter ended Mar 2025 and 13.26 for the financial year 2023-24.
The shareholding pattern of Tatva Chintan Pharma is as follows:
  • DIIs - 5.46%
  • FII - 3.30%
  • Promoters - 72.02%
  • Public Investors 16.92%
  • Goverenment - 0.00%
Yes, you can buy shares of Tatva Chintan Pharma online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Tatva Chintan Pharma stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Tatva Chintan Pharma share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Tatva Chintan Pharma.
You can easily buy the shares of Tatva Chintan Pharma even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in TATVA
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Moneylicious Securities Private Limited. All rights reserved. CIN: U74999MH2012PTC433549 Moneylicious Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Moneylicious Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Moneylicious Securities Private Limited. All DHAN clients are registered under Moneylicious Securities Private Limited. Clients are advised to refer to our company as Moneylicious Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / Moneylicious / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Moneylicious Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors